Cargando…
Surrogate end points and their role in clinical trials: Reply from authors
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825019/ https://www.ncbi.nlm.nih.gov/pubmed/20177586 http://dx.doi.org/10.4103/0253-7613.48879 |
| _version_ | 1782177775862415360 |
|---|---|
| author | Kalikar, M.V. Thawani, V.R. Varadpande, U.K. Sontakke, S.D. Singh, R.P. Khiyani, R.K. |
| author_facet | Kalikar, M.V. Thawani, V.R. Varadpande, U.K. Sontakke, S.D. Singh, R.P. Khiyani, R.K. |
| author_sort | Kalikar, M.V. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2825019 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | Medknow Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28250192010-02-22 Surrogate end points and their role in clinical trials: Reply from authors Kalikar, M.V. Thawani, V.R. Varadpande, U.K. Sontakke, S.D. Singh, R.P. Khiyani, R.K. Indian J Pharmacol Correspondence Medknow Publications 2009-02 /pmc/articles/PMC2825019/ /pubmed/20177586 http://dx.doi.org/10.4103/0253-7613.48879 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Kalikar, M.V. Thawani, V.R. Varadpande, U.K. Sontakke, S.D. Singh, R.P. Khiyani, R.K. Surrogate end points and their role in clinical trials: Reply from authors |
| title | Surrogate end points and their role in clinical trials: Reply from authors |
| title_full | Surrogate end points and their role in clinical trials: Reply from authors |
| title_fullStr | Surrogate end points and their role in clinical trials: Reply from authors |
| title_full_unstemmed | Surrogate end points and their role in clinical trials: Reply from authors |
| title_short | Surrogate end points and their role in clinical trials: Reply from authors |
| title_sort | surrogate end points and their role in clinical trials: reply from authors |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825019/ https://www.ncbi.nlm.nih.gov/pubmed/20177586 http://dx.doi.org/10.4103/0253-7613.48879 |
| work_keys_str_mv | AT kalikarmv surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors AT thawanivr surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors AT varadpandeuk surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors AT sontakkesd surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors AT singhrp surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors AT khiyanirk surrogateendpointsandtheirroleinclinicaltrialsreplyfromauthors |